MAR
57
3
UHS
50
4
DHI
36
3
ITW
45
2
FITB
36
3
PSA
43
6
BXP
39
5
FIS
43
5
ILMN
31
4
ABBV
40
5
CFG
36
12
MSFT
55
2
UAL
73
3
NKE
36
2
ED
39
8
NDAQ
46
2
AIV
39
6
AA
27
5
MHK
25
5
MRK
25
2
MAR
57
3
UHS
50
4
DHI
36
3
ITW
45
2
FITB
36
3
PSA
43
6
BXP
39
5
FIS
43
5
ILMN
31
4
ABBV
40
5
CFG
36
12
MSFT
55
2
UAL
73
3
NKE
36
2
ED
39
8
NDAQ
46
2
AIV
39
6
AA
27
5
MHK
25
5
MRK
25
2
Financhill
Back

Sabra Health Care REIT Vs. Novo Nordisk AS Industry Stock Comparison

Sell
41

SBRA
Sabra Health Care REIT

Last Price:
$16.98
Seasonality Move:
2.04%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
41
Sabra Health Care REIT (SBRA) is a Sell

Is Sabra Health Care REIT a Buy, Sell or Hold?

  • The current Sabra Health Care REIT [SBRA] share price is $16.96. The Score for SBRA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SBRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SBRA Stock Price Chart

What is Sabra Health Care REIT's stock price today?

  • The Sabra Health Care REIT share price today is $16.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SBRA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

SBRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 35.02 Sell
Chaikin Money Flow: 2687029 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.42 - 18.62) Sell
Bollinger Bands (100): (16.91 - 18.91) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

SBRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.27 Sell
20-day SMA: 17.94 Sell
50-day SMA: 18.41 Sell
200-day SMA: 16.28 Buy
8-day EMA: 17.26 Sell
20-day EMA: 17.75 Sell
50-day EMA: 18.06 Sell
200-day EMA: 16.68 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Sabra Health Care REIT Earnings Growth & SBRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $0.17 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Sabra Health Care REIT Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):